Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for interferon beta-1a (compound)
Most Correlated Studies
- IFNb1a treatment of mononuclear cells from Multiple Sclerosis patients
- Multiple sclerosis patients in remission and relapse
- PBMCs from clinically isolated syndrome patients after IFNb1a treatment
- Cortical neurons exposed to excitotoxic NMDA and potentially neuroprotective compounds
- PBMCs from multiple sclerosis patients treated with Betaferon or Rebif
Most Relevant Literature
- The impact of metformin use on the outcomes of relapse-remitting multiple sclerosis patients receivi…
- Patient-reported outcomes are the strongest predictors of disease disability in intramuscular interf…
- Assessment of adherence to, and persistence with, an electromechanical autoinjector for subcutaneous…
- A randomized pharmacokinetic-pharmacodynamic evaluation of the potential biosimilar interferon beta-…
- Temporal evolution of new T1-weighted hypo-intense lesions and central brain atrophy in patients wit…
Most Relevant Clinical Trials
- Pharmacodynamic Biomarkers to Support Biosimilar Development: Interferon Beta-1A Products
- Pharmacokinetics and Pharmacodynamics of the Interferon Beta-1a Produced by Laboratorio Quimico Farm…
- A Pilot Trial of Interferon Beta-1a in Alzheimer's Disease
- Safety Study of Interferon Beta 1a to for Acute Stroke
- Does Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a?
